Suppr超能文献

酮康唑对大鼠肝脏微粒体单加氧酶的急性和亚慢性影响。

The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the rat.

作者信息

Thomson R G, Rawlins M D, James O F, Wood P, Williams F M

机构信息

Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne, U.K.

出版信息

Biochem Pharmacol. 1988 Oct 15;37(20):3975-80. doi: 10.1016/0006-2952(88)90082-2.

Abstract

Female adult Wistar rats were treated with single or repeated doses of ketoconazole ranging from 10 mg/kg to 100 mg/kg. Single dose treatment produced inhibition of hepatic microsomal ethoxyresorufin O-deethylation (EROD) and aldrin epoxidation (AE) 2 hr after oral dosing. Twenty-four hours after a single dose, inhibition was still demonstrable after the low dose of 10 mg/kg, but at higher doses increased microsomal activity was apparent. After 7 days repeated dosing liver weight and microsomal protein content were increased in a dose-dependent fashion. EROD and AE were induced at all doses after repeated treatment when the increase in liver size was considered. These effects were seen at doses within the antimycotic therapeutic range and add support to the suggestion that reported drug interactions with ketoconazole in man are due to the effects of this drug on hepatic microsomal activity.

摘要

成年雌性Wistar大鼠接受了单次或重复剂量的酮康唑治疗,剂量范围为10毫克/千克至100毫克/千克。单次给药后2小时,单剂量治疗导致肝微粒体乙氧基试卤灵O-脱乙基酶(EROD)和艾氏剂环氧化酶(AE)受到抑制。单次给药24小时后,低剂量10毫克/千克时仍可显示出抑制作用,但在较高剂量时,微粒体活性增加明显。重复给药7天后,肝脏重量和微粒体蛋白含量呈剂量依赖性增加。考虑到肝脏大小增加的因素,重复治疗后所有剂量均诱导了EROD和AE。这些效应在抗真菌治疗范围内的剂量下即可观察到,这支持了以下观点,即报告的人体中酮康唑与其他药物的相互作用是由于该药物对肝微粒体活性的影响所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验